Article Text

Download PDFPDF
Rh Prevention: A Report and Analysis of a National Programme
  1. J. Eklund,
  2. H. R. Nevanlinna
  1. 1Finnish Red Cross Blood Transfusion Service, Helsinki 31, Finland


    A nation-wide Rh prevention programme was started in Finland in 1969. Before that, a control series of approximately 1000 Rh-negative mothers giving birth to an Rh-positive child was collected to estimate the number of mothers with antibodies at either three, six, or nine months post partum. During the three-and-a-half year period altogether 14,980 Rh-negative patients were given 250 μg of anti-D immunoglobulin prepared from Finnish raw material in the Central Laboratory of the Dutch Red Cross. Out of those treated before the end of June 1972, 12,720 (97%) were tested four to six months post partum. Seventeen or 0·13% had detectable antibodies; in five of them the infant was ABO incompatible. The number of protected mothers with a subsequent Rh-positive infant was 1017; 10 had formed antibodies before the delivery of the second child.

    The risk of primary immunization initiated during a single pregnancy was estimated to be 0·35%. In addition, there was approximately a 0·60% risk of forming antibodies by the next Rh-positive pregnancy.

    The effect of prevention on the prevalence of haemolytic disease was calculated and compared with observed figures.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.